RE.GA.IN.:真实世界胃炎倡议——更新再更新
真实世界胃炎倡议(RE.GA.IN.)汇集五大洲胃炎学者,经逾8个月全球科学讨论后于2022年11月在威尼斯形成共识,围绕胃炎流行病学、幽门螺杆菌作为环境性胃炎主要病因及胃癌发生领域最重要决定因素、胃自身免疫、胃微生物群、内镜诊断新视野及组织学胃炎分期报告等主题给出以患者为中心、循证的声明。
要点
- 幽门螺杆菌是环境性胃炎的主导病因,也是胃致癌领域最重要的决定因素。
- 共识聚焦胃炎流行病学、胃自身免疫、胃微生物群及内镜诊断新视野。
- 组织学报告胃炎应重视分期,作为临床优先事项。
核心结论
- RE.GA.IN.共识旨在推动胃炎患者临床管理进一步改善。
研究设计与样本
- RE.GA.IN.共识由五大洲胃炎学者参与的多学科论坛形成,历经逾8个月全球科学讨论后于2022年11月在威尼斯完成。
主要发现
- 共识报告聚焦胃炎流行病学、幽门螺杆菌作为环境性胃炎主导病因及胃致癌领域最重要决定因素、胃自身免疫认识进展、胃微生物群的临床病理相关性、内镜诊断新视野及组织学报告胃炎分期。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At the end of the last century, a far-sighted 'working party' held in Sydney, Australia addressed the clinicopathological issues related to gastric inflammatory diseases. A few years later, an international conference held in Houston, Texas, USA critically updated the seminal Sydney classification. In line with these initiatives, Kyoto Global Consensus Report, flanked by the Maastricht-Florence conferences, added new clinical evidence to the gastritis clinicopathological puzzle.The most relevant topics related to the gastric inflammatory diseases have been addressed by the Real-world Gastritis Initiative (RE.GA.IN.), from disease definitions to the clinical diagnosis and prognosis. This paper reports the conclusions of the RE.GA.IN. consensus process, which culminated in Venice in November 2022 after more than 8 months of intense global scientific deliberations. A forum of gastritis scholars from five continents participated in the multidisciplinary RE.GA.IN. consensus. After lively debates on the most controversial aspects of the gastritis spectrum, the RE.GA.IN. Faculty amalgamated complementary knowledge to distil patient-centred, evidence-based statements to assist health professionals in their real-world clinical practice. The sections of this report focus on: the epidemiology of gastritis; Helicobacter pylori as dominant aetiology of environmental gastritis and as the most important determinant of the gastric oncogenetic field; the evolving knowledge on gastric autoimmunity; the clinicopathological relevance of gastric microbiota; the new diagnostic horizons of endoscopy; and the clinical priority of histologically reporting gastritis in terms of staging. The ultimate goal of RE.GA.IN. was and remains the promotion of further improvement in the clinical management of patients with gastritis.
引用
- Rugge M, Genta RM, Malfertheiner P, et al. RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates. Gut. 2024. PMID: 38383142. doi:10.1136/gutjnl-2023-331164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。